Skip navigation
Home
Menu
Menu
Study
Student life
Research and innovation
Global
About us
Staff
Students
Search the site
Centre of Excellence for Long-acting Therapeutics
Menu
About us
LONGEVITY
HALo
Nanotherapeutics Hub
Teoreler
PKRxiv
LAPaL
Blog
Our News
Events
Contact us
News
UNAIDS calls on leaders at Davos to commit to rapid global access to revolutionary new long-acting HIV medicines
24 January 2025
Novo Holdings invests in $200M Series A for Windward Bio launch to advance long-acting treatments for asthma and COPD
17 January 2025
Long-acting Injectables: Microsphere Design, Development and Scale-up Using Lactide/Glycolide-Based Polymers, Upcoming Webinar Hosted by Xtalks
17 January 2025
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform
17 January 2025
Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral
17 January 2025
WHO announces the development of new guidelines for lenacapavir and updated HIV testing guidelines
10 January 2025
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody
27 December 2024
ViiV Healthcare announces CHMP positive opinion for Vocabria + Rekambys, the first and only complete long-acting HIV treatment, for adolescents in Europe
20 December 2024
Johnson & Johnson denied extension of patent on TB drug, to benefit patients
20 December 2024
Newer stories
Older Stories